Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//PSYCHOLOGY, EXPERIMENTAL | 1830502 |
299 | 3 | PARKINSONS DISEASE//ALPHA SYNUCLEIN//MOVEMENT DISORDERS | 41610 |
1272 | 2 | MPTP//PARKINSONS DISEASE//MONOAMINE OXIDASE | 9090 |
8357 | 1 | SELEGILINE//RASAGILINE//DEPRENYL | 1291 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | SELEGILINE | authKW | 2704649 | 15% | 55% | 200 |
2 | RASAGILINE | authKW | 2611300 | 11% | 73% | 147 |
3 | DEPRENYL | authKW | 1941458 | 11% | 54% | 146 |
4 | L DEPRENYL | authKW | 1001415 | 4% | 71% | 58 |
5 | SAFINAMIDE | authKW | 401721 | 2% | 69% | 24 |
6 | EVE TOPF EXCELLENCE NEURODEGENERAT DIS | address | 302928 | 2% | 56% | 22 |
7 | R P ORT FAMILY | address | 220290 | 1% | 48% | 19 |
8 | DESMETHYLSELEGILINE | authKW | 219700 | 1% | 100% | 9 |
9 | DEPRENYL SELEGILINE | authKW | 187773 | 1% | 77% | 10 |
10 | MAO B INHIBITION | authKW | 174359 | 1% | 71% | 10 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Clinical Neurology | 5164 | 28% | 0% | 364 |
2 | Neurosciences | 4678 | 36% | 0% | 462 |
3 | Pharmacology & Pharmacy | 4650 | 36% | 0% | 462 |
4 | Geriatrics & Gerontology | 751 | 4% | 0% | 57 |
5 | Psychiatry | 207 | 6% | 0% | 73 |
6 | Medicine, Research & Experimental | 113 | 5% | 0% | 61 |
7 | Toxicology | 57 | 3% | 0% | 36 |
8 | Behavioral Sciences | 55 | 2% | 0% | 25 |
9 | Chemistry, Medicinal | 46 | 3% | 0% | 33 |
10 | Chemistry, Analytical | 28 | 4% | 0% | 47 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | EVE TOPF EXCELLENCE NEURODEGENERAT DIS | 302928 | 2% | 56% | 22 |
2 | R P ORT FAMILY | 220290 | 1% | 48% | 19 |
3 | EVE TOPF | 152562 | 1% | 63% | 10 |
4 | EVE TOPF NEURODEGENERAT DIS | 134250 | 1% | 50% | 11 |
5 | EVE TOPF USA PARKINSON FDN EXCELLENCE | 111587 | 1% | 57% | 8 |
6 | EVE TOPF NPF | 97644 | 0% | 100% | 4 |
7 | NPF | 87875 | 0% | 60% | 6 |
8 | CENT ISOTOPE | 81357 | 1% | 33% | 10 |
9 | NPF NEURODEGENERAT DIS | 78114 | 0% | 80% | 4 |
10 | R P ORT FAMILY MED | 58084 | 1% | 18% | 13 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT | 37738 | 3% | 4% | 35 |
2 | JOURNAL OF NEURAL TRANSMISSION | 19688 | 4% | 1% | 58 |
3 | CLINICAL NEUROPHARMACOLOGY | 8437 | 2% | 1% | 29 |
4 | JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION | 5326 | 1% | 3% | 7 |
5 | ACTA NEUROLOGICA SCANDINAVICA | 5093 | 3% | 1% | 36 |
6 | MOVEMENT DISORDERS | 4208 | 3% | 1% | 34 |
7 | JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION | 3136 | 1% | 1% | 9 |
8 | POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY | 3126 | 1% | 1% | 10 |
9 | PARKINSONISM & RELATED DISORDERS | 2189 | 1% | 1% | 15 |
10 | BIBLIOTHECA PSYCHIATRICA | 2119 | 0% | 4% | 2 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SELEGILINE | 2704649 | 15% | 55% | 200 | Search SELEGILINE | Search SELEGILINE |
2 | RASAGILINE | 2611300 | 11% | 73% | 147 | Search RASAGILINE | Search RASAGILINE |
3 | DEPRENYL | 1941458 | 11% | 54% | 146 | Search DEPRENYL | Search DEPRENYL |
4 | L DEPRENYL | 1001415 | 4% | 71% | 58 | Search L+DEPRENYL | Search L+DEPRENYL |
5 | SAFINAMIDE | 401721 | 2% | 69% | 24 | Search SAFINAMIDE | Search SAFINAMIDE |
6 | DESMETHYLSELEGILINE | 219700 | 1% | 100% | 9 | Search DESMETHYLSELEGILINE | Search DESMETHYLSELEGILINE |
7 | DEPRENYL SELEGILINE | 187773 | 1% | 77% | 10 | Search DEPRENYL+SELEGILINE | Search DEPRENYL+SELEGILINE |
8 | MAO B INHIBITION | 174359 | 1% | 71% | 10 | Search MAO+B+INHIBITION | Search MAO+B+INHIBITION |
9 | ENHANCER SUBSTANCES | 170877 | 1% | 100% | 7 | Search ENHANCER+SUBSTANCES | Search ENHANCER+SUBSTANCES |
10 | ALIPHATIC PROPARGYLAMINES | 132902 | 1% | 78% | 7 | Search ALIPHATIC+PROPARGYLAMINES | Search ALIPHATIC+PROPARGYLAMINES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |